Announcements Trials
Browse Landscape

Status

Completed 2698Recruiting 1115Unknown 977Terminated 695Active not recruiting 442Not yet recruiting 306Withdrawn 272Enrolling by invitation 31Suspended 26No longer available 7Available 1Approved for marketing 1

Sponsor Class

INDUSTRY 12OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 7Tumor-Agnostic 5Other hematologic neoplasm 4Sarcoma 3Head & Neck 3Endocrine 3Thoracic 2Myeloid 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Plasma cell 1NET 1Lymphoid 1Classical hematology 1

Conditions

Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1Hematologic Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1Adrenoleukodystrophy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × OTHER × Lymphoid × Clear all
NCT01881334 2025-11-20

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Duke University

Available
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adrenoleukodystrophy, Anemia, Aplastic, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡